New Report Highlights Dramatic Change In U.S. Drug Spending Trends, Policy ImplicationsA major reduction in real prescription drug spending growth has created a "turning point" in healthcare with several policy implications, according to a study published this month by the journal Health Affairs as a Web Exclusive. The report, "Prescription Drug Spending Trends in the United States: Looking Beyond the Turning Point," uses IMS Health (NYSE: RX) information adjusted for inflation to document that U.S.
Clinical Pharmacists Can Reduce Drug Costs Clinical pharmacy services can significantly reduce the cost of prescription drugs and save money elsewhere in the health care system, according to a new study by researchers at the University of Illinois at Chicago. For every dollar spent by hospitals or health systems to provide clinical pharmacy services, $4.
Clinical Pharmacists Can Reduce Drug CostsClinical pharmacy services can significantly reduce the cost of prescription drugs and save money elsewhere in the health care system, according to a new study by researchers at the University of Illinois at Chicago. For every dollar spent by hospitals or health systems to provide clinical pharmacy services, $4.
NPA Restructures Executive Team, UKThe NPA is restructuring its executive team. The new structure will reflect the core elements of the NPA's remit - representation, support and protection. The three directorates: External Affairs, Membership Services and Insurance will be supported by a Finance Directorate.
Collaboration Between USP And NIBSC To Improve Quality Standards For Biological MedicinesTo improve the quality of the rapidly expanding array of biological medicines, the U.S. Pharmacopeial (USP) Convention has entered into a Memorandum of Understanding (MOU) with the National Biological Standards Board, which manages the National Institute for Biological Standards and Control (NIBSC) of the United Kingdom. Biological medicines are made with materials derived from plants or animals, rather than those created in a chemical laboratory.
Cough And Cold Medicines Not For Children Under 6, Says Health CanadaManufacturers in Canada will have to relabel OTC (over-the-counter) cough and cold medicines that have pediatric dosing information to indicate that these medications should not be given to children under six years of age. Health Canada says the products affected are those that contain any of the active ingredients listed below that are administered orally (via the mouth).
Stem Cells Drug Testing Predicted To Boom Under ObamaEmbryonic stem cells could provide a new way of testing drugs for dangerous side effects, according to a leading British researcher. Speaking at the British Pharmacological Society's Winter Meeting in Brighton, Christine Mummery, Professor of Developmental Biology at Leiden University Medical Centre in The Netherlands, predicts that what is currently a small and sparsely funded research area will boom in coming years.
No Change To Dispensing Doctor Arrangements: NPA StatementReacting to the news that Phil Hope Minister of State has announced in the House that there will be will be no change to the current arrangements on GPs dispensing medicines to their patients. John Turk, NPA Chief Executive, comments: "Its good that ministers have decided to quickly act on this matter that dominated the current consultation process, overshadowing the broader, positive agenda set out in the Pharmacy in England White Paper.
![](\"http://www.igotyourindex.com/igyindex.gif?DOCUMENTNAME=&DOCUMENTLINK=&GOALNAME&=DOCUMENTVALUE&=GROUPNAME\")